Aronson R A, Cook S L, Roche J K
J Immunol. 1983 Dec;131(6):2796-804.
To explore the autoantigenic potential of mucosal epithelium that is the site of several chronic, progressive, inflammatory and yet idiopathic diseases, epithelial cell-associated components (designated ECAC) have been isolated in aqueous-soluble form from everted, inflated loops of murine small intestine, initially characterized biochemically and immunologically, and then purified to homogeneity and studied for a disease association through quantitating, by microcytotoxicity assay, their reactivity with patient mononuclear cells and sera. Hydroxyapatite chromatography successfully separated ECAC into several series of major and minor components, with each series (designated 1, 2A, 2B, and 2C) having a unique chemical profile in terms of total carbohydrate, protein, and specific sugars (sialic acid, fucose, galactose). Furthermore, components within each series were shown not to behave as simple blood group substances antigenically, to be free of contaminating intestinal proteases (less than 0.25 micrograms chymotrypsin or equivalent per milliliter) and to possess shared as well as unique antigenic determinants (1 through 4), all of which appeared to be organ-specific for intestine. Gel filtration on Sephacryl S-200 gave a four-peak elution profile for ECAC consistent with a m.w. for components of 3000 to 232,000. Preparative polyacrylamide gel electrophoresis did isolate individual constituents of ECAC, four of which (P1, P2, P4, and P5) were homogeneous and that could, by a hemagglutination inhibition technique, be shown to possess unique organ-specific antigenic determinants. ECAC-specific reactivity of peripheral blood mononuclear cells and sera from patients in the active phase of a chronic inflammatory disorder involving mucosal epithelium indicated autosensitization had occurred, with involvement of several purified epithelium-derived macromolecules. This reactivity appeared to be antibody dependent, occurred at relatively low effector to target ratios, and was not simultaneously directed to control antigens, isolated from kidney in a manner analogous to that used for ECAC. ECAC, isolated by these techniques, may be sufficiently purified to allow an evaluation of their role in the initiation and/or progression of chronic autoaggressive processes occurring in mucosa.
为了探究作为多种慢性、进行性、炎症性且病因不明疾病发病部位的黏膜上皮的自身抗原潜力,已从鼠小肠外翻、充气肠袢中以水溶性形式分离出上皮细胞相关成分(简称ECAC),首先对其进行生化和免疫学特性鉴定,然后纯化至同质,并通过微量细胞毒性试验定量检测其与患者单核细胞和血清的反应性,研究其与疾病的关联。羟基磷灰石色谱成功地将ECAC分离成几个主要和次要成分系列,每个系列(分别命名为1、2A、2B和2C)在总碳水化合物、蛋白质和特定糖类(唾液酸、岩藻糖、半乳糖)方面具有独特的化学特征。此外,每个系列中的成分在抗原性上并非简单的血型物质,不含肠道蛋白酶污染(每毫升少于0.25微克胰凝乳蛋白酶或等效物),并具有共同以及独特的抗原决定簇(1至4),所有这些似乎都是肠道器官特异性的。在Sephacryl S - 200上进行凝胶过滤,得到ECAC的四峰洗脱图谱,与分子量为3000至232,000的成分一致。制备性聚丙烯酰胺凝胶电泳确实分离出了ECAC的各个成分,其中四个(P1、P2、P4和P5)是同质的,并且通过血凝抑制技术可以证明它们具有独特的器官特异性抗原决定簇。来自涉及黏膜上皮的慢性炎症性疾病活动期患者的外周血单核细胞和血清对ECAC的特异性反应表明已经发生了自身致敏,涉及几种纯化的上皮来源大分子。这种反应似乎依赖抗体,在相对较低的效应细胞与靶细胞比例下发生,并且不同时针对以类似于用于ECAC的方式从肾脏分离的对照抗原。通过这些技术分离的ECAC可能已充分纯化,从而能够评估它们在黏膜中发生的慢性自身攻击过程的起始和/或进展中的作用。